Armistice Capital, LLC Oramed Pharmaceuticals Inc. Transaction History

Armistice Capital, LLC

  • $7.69 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$2.95 - $3.64 $1.6 Million - $1.98 Million
-542,944 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$3.0 - $4.94 $243,168 - $400,416
-81,056 Reduced 12.99%
542,944 $1.63 Million
Q3 2018

Nov 14, 2018
BUY
$4.64 - $7.11 $2.9 Million - $4.44 Million
624,000 New
624,000 $3.04 Million

Others Institutions Holding ORMP

# of Institutions
65
Shares Held
6.37M
Call Options Held
0
Put Options Held
0
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $91.2M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email